BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent

BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent

VANCOUVER, BC / ACCESS Newswire / May 23, 2025 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the examining division of the European Patent…

BioNxt Solutions Inc. (‘BioNxt' or the ‘Company') (CSE: BNXT) (OTC PINK: BNXTF) (FWB: BXT), a bioscience sinnovator specializing in advanced drug delivery systems, is pleased to announce that the Examining Division of the European Patent Office (‘EPA') has formally notified the EPO of its intention to grant BioNxt its core patent without significant changes.

BioNxt Solutions Reports Formal Notice from the European Patent Office of Intention to Grant Patent - European Business & Finance Magazine

VANCOUVER, BC / ACCESS Newswire / May 23, 2025 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTC PINK:BNXTF)(FSE:BXT), a bioscience innovator specializing in advanced drug delivery systems, is pleased to announce that the examining division of the European Patent Office (“EPO”) has provided formal notice of the EPO‘s intention to grant BioNxt its core patent without significant changes. The Company’s core patent filing was a com…